Five-Year Visual Function and Refractive Outcomes After Congenital Cataract Surgery
Launched by JIN YANG · Jul 15, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how children’s vision develops over five years after they have surgery to remove cataracts they were born with. Cataracts are cloudy areas in the eye that can affect sight, and this study focuses on children who had their cataracts removed before they turned one year old. The researchers want to see how well these children can see with the best possible correction (like glasses), how well they perceive depth (called stereopsis), changes in their eye’s focusing ability, and how their eyes grow over time. Understanding these long-term results will help doctors better predict and improve vision outcomes for kids treated early for congenital cataracts.
Children who were diagnosed with congenital cataracts and had surgery before their first birthday may be eligible to join, as long as they don’t have other eye problems or health conditions that affect vision, and they can commit to regular eye check-ups for at least five years after surgery. Parents or guardians will need to give written permission for their child to participate. If enrolled, families can expect ongoing eye exams to monitor vision and eye growth, helping researchers gather important information about how early cataract surgery impacts vision in the long run. This study is currently looking for participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of congenital cataract
- • Underwent cataract extraction before 1 year of age
- • Available for regular follow-up for at least 5 years postoperatively
- • Written informed consent from legal guardian
- Exclusion Criteria:
- • Acquired cataract or traumatic origin
- • Associated ocular malformations (e.g., microphthalmia, coloboma)
- • Systemic syndromes affecting vision (e.g., Down syndrome)
- • History of secondary surgery affecting visual outcome
About Jin Yang
Jin Yang is a clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on developing effective and safe therapeutic solutions, Jin Yang collaborates with healthcare professionals and research institutions to conduct rigorous clinical studies. Committed to upholding the highest standards of scientific integrity and patient safety, Jin Yang plays a vital role in contributing to the improvement of healthcare outcomes worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Jin Yang
Study Chair
Fudan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported